NCT06737107

Brief Summary

The study is a retrospective, observational and multicentric study. The study describes robotic segmentectomies performed in four referred centers, with the aim to assess the perioperative compilications of robotic segmentectomies compared to video-assisted thoracoscopic surgery (VATS) and open approach.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
472

participants targeted

Target at P75+ for all trials

Timeline
0mo left

Started Nov 2024

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Nov 2024May 2026

Study Start

First participant enrolled

November 26, 2024

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

December 5, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

1 year

First QC Date

December 5, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

Video-Assisted Thoracoscopic Surgeryopen approachRobot-Assisted Thoracoscopic Surgery

Outcome Measures

Primary Outcomes (3)

  • The perioperative complications of robotic approach

    The investigators will measure the perioperative complications of robotic lung resection in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.

    from the surgery at 30-90 days after

  • The perioperative complication of video-assisted thoracoscopic surgery (VATS) approach

    The investigators will measure the perioperative complications of video-assisted thoracoscopic surgery (VATS) appraoch in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.

    30-90 days after surgery

  • The perioperative complications of the open approach

    The investigators will measure the perioperative complications of open approach in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.

    30-90 days after surgery

Secondary Outcomes (4)

  • Duration of surgery

    up to 1 month

  • Quality of lymphadenectomy

    up to 1 month

  • Conversion rate

    up to 1 month

  • Survival analysis

    up to 5 years

Study Arms (2)

Case group : Robotic Approach

Patients with a pre or post-operative diagnosis of NSCLC surgically treated with robotic segmentectomy from 1st January 2010 to the 31st to December 2023

Control group: video-assisted thoracoscopic surgery (VATS) and open

Patients with a pre or post-operative diagnosis of NSCLC surgically treated with video-assisted thoracoscopic surgery (VATS) and open segmentectomy from 1st January 2010 to the 31st to December 2023

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients that underwent segmentectomies from the 1st January 2010 to the 31st of December 2023 treated with robotic segmentectomy (case) and video-assisted thoracoscopic (VATS) or open segmentectomy (control)

You may qualify if:

  • Pre or post-operative diagnosis of NSCLC surgically treated with pulmonary segmentectomy from 1st January 2010 to the 31st to December 2023.
  • Age \> then 18 years at the moment of surgery

You may not qualify if:

  • Age \< then 18 years at the moment of surgery
  • diagnosis other than NSCLC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Istituto Clinico Humanitas

Rozzano, Milan, 20089, Italy

RECRUITING

Scientific Institute Ospedale San Raffaele

Milan, 20132, Italy

RECRUITING

Istituto Europeo di Oncologia

Milan, 20141, Italy

RECRUITING

Policlinico Universitario Agostino Gemelli

Rome, 30151, Italy

RECRUITING

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Pierluigi Novellis, Medical Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 17, 2024

Study Start

November 26, 2024

Primary Completion

December 5, 2025

Study Completion (Estimated)

May 31, 2026

Last Updated

December 17, 2024

Record last verified: 2024-12

Locations